Harmful Microinjecting Practices Among a Cohort of Injection Drug Users in Vancouver Canada

References

• Abreu, M. E., Bigelow, G. E., Fleisher, L., Walsh, S. L. (2001). Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology, 154:76–84.
   PubMed Web of Science ®Google Scholar
• Aceijas, C., Stimson, G. V., Hickman, M., Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS, 18:2295–2303.
   PubMed Web of Science ®Google Scholar
• Broadhead, R. S., Heckathorn, D. D., Weakliem, D. L., Anthony, D. L., Madray, H., Mills, R. J., (1998). Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Reports, 113:42–57.
   PubMed Web of Science ®Google Scholar
• Buxton, J. (2003). Vancouver drug Use Epidemiology. Site Report for the Canadian Community Epidemiology of drug Use. Accessed November 10, 2005, from www.vancouver.ca/ Foupillaro/pdf/report_vancouver_2003.pdf
   Google Scholar
• Buxton, J. (2007). Vancouver drug use epidemiology. Vancouver, Canada: Canadian Community Epidemiology Network on Drug Use.
   Google Scholar
• Buxton, J. A., Preston, E. C., Mak, S., Harvard, S., Barely, J., and BC Harm Reduction supply distribution in British Columbia. (2008). More than just needles: an evidence-informed approach to enhancing harm reduction supply distribution in British Columbia. Harm Reduction Journal, 5:37.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Vlahov, D., Cohn, S., Anthony, J. C., Solomon, L., Nelson, K. E. (1991). Risk factors for shooting gallery use among intravenous drug users. American Journal of Public Health, 811, 1291–1295.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2009). HIV infection among injection drug users-34 states, 2004–2007. MMWR Morbidity and Mortality Weekly, 58:1291–1295.
   PubMedGoogle Scholar
• Ceste, J. (2007). Aids and Public Security: The other side of the coin. Lancet, 369:720–721.
   PubMedGoogle Scholar
• Corneil, T. A., Kuyper, L. M., Shoveller, J., Hogg, R. S., Li, K., Spittal, P. M., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health and Place, 12:79–85.
   PubMed Web of Science ®Google Scholar
• Csete, J., Cohen, J. (2003). Human rights in Vancouver: Do injection drug users have a fuend in city hall. Canadian HIV/AID Policy and Law Review, 8:7–10.
   Google Scholar
• Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51:253–263.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Semaan, S., Wood, E. (2009). HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. Current Opinions on HIV/AIDS, 4:308–313.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., (2000). HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. American Journal of Public Health, 90:352–359.
   PubMed Web of Science ®Google Scholar
• Dovey, K., Fitzgerald, J. L., Choi, Y. (2001). Safety becomes danger: dilemmas of drug-use in public space. Health and Place, 7, 319–331.
   PubMed Web of Science ®Google Scholar
• Dwyer, R., Topp, L., Maher, L., Power, R., Hellard, M., Walsh, N., (2009). Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug and Alcohol Dependence, 100:9–16.
   PubMed Web of Science ®Google Scholar
• Eby, D. (2006). The political power of police and crackdowns: Vancouver's example. International Journal of Drug Policy, 17:96–100.
   Google Scholar
• Fast, D., Small, W., Wood, E., Kerr, T. (2008). The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduction Journal, 5:32.
   PubMedGoogle Scholar
• Freeman, R., Williams, M. L., Sanders, L. A. (1999). Drug use, AIDS knowledge and HIV risk behaviours of Cuban-, Mexican-, and Puerto Rican-born drug injectors who are recent entrants into the United States. Substance Use and Misuse, 34:1765–1793.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Reid, G. (2002). The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology, 22:177–200.
   Google Scholar
• Galea, S., Nandi, A., Vlahov, D. (2004). The social epidemiology of drug use. Epidemiologic Reviews, 26:36–52.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Des Jarlais, D. C. (2000). HIV and HCV infection among injecting drug users. Mt. Sinai Journal of Medicine, 67:423–428.
   PubMed Web of Science ®Google Scholar
• Hamers, F. F., Batter, V., Downo, A. M., Alix, J., Cazein, F., Brunet, J. B. (1997). The HIV epidemic associated with injection drug use in Europe: geographic and time trends. AIDS, 11:1365–1374.
   PubMedGoogle Scholar
• Haw, S., Higgins, K. (1998). A comparison of the prevalence of HIV infection and injecting risk behaviour in urban and rural samples in Scotland. Addiction, 93:855–863.
   PubMed Web of Science ®Google Scholar
• Hurley, S. F., Jolley, D. J. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797–1801.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Small, W., Peeace, W., Douglas, D., Pierre, A., Wood, E. (2006). Harm reduction by a ‘user-run’ organization: a case study of the Vancouver Area Network of Drug Users (VANDU). International Journal of Drug Policy, 17:61–69.
   Web of Science ®Google Scholar
• Kleinig, J., Einstein, S., (2006). Ethical challenges for intervening in drug use: policy, research and treatment issues. Huntsville, TX: OICJ.
   Google Scholar
• Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., Kerr, T. (2008). Risk factors for developing cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health, 9:405.
   Google Scholar
• Lloyd-Smith, E., Kerr, T., Hogg, R. S., Li, K., Montaner, J. S., Wood, E. (2005). Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduction Journal, 2:24.
   PubMedGoogle Scholar
• Maas, B., Fairbairn, N., Kerr, T., Li, K., Montaner, J. S. G., Wood, E. (2007). Neighbourhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health and Place, 17:432–439.
   Google Scholar
• Magura, S., Kang, S. Y., Nwakeze, P. C., Demsky, S. (1998). Temporal patterns of heroin and cocaine use among methadone patients. Substance Use and Misuse, 33:2441–2467.
   PubMed Web of Science ®Google Scholar
• Maher, L., Dixon, D. (1995). Policing and public health: law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39:488–512.
   Google Scholar
• Miller, C., Strathdee, S. A., Kerr, T., Li, K., Wood, E. (2006a). Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. Journal of Adolescent Health, 38:462–464.
   PubMed Web of Science ®Google Scholar
• Miller, C. L., Kerr, T., Frankish, J. C., Spittal, P. M., Li, K., Schechter, M. T., (2006b). Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Substance Use and Misuse, 41:199–210.
   PubMed Web of Science ®Google Scholar
• Milloy, M. J., Wood, E., Small, W., Tyndall, M., Lai, C., Montaner, J., (2008). Incarceration experiences in a cohort of active injection drug users. Drug and Alcohol Review, 27:693–699.
   PubMed Web of Science ®Google Scholar
• Ouellet, L., Jimenez, A. D., Johnson, W., Wiebel, W. (1991). Shooting galleries and HIV disease variations in places for injecting illicit drugs. Crime and Deliquency, 37:64–85.
   Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Leon, H., Muller, J., O’Shaughnessy, M. V., Schechter, M. T., (2001). Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal,165;415–420.
   Google Scholar
• Patrick, D. M., Tyndall, M. W., Cornelisse, P. G., Li, K., Sherlock, C. H., Rekart, M. L., (2001). Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ, 165:889–895.
   PubMed Web of Science ®Google Scholar
• Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STDs and AIDS, 8:437–445.
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (2002). The ‘risk’ environment: a framework for understanding and reducing drug related harm. International Journal of Drug Policy, 13:85–94.
   Google Scholar
• Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61:1026–1044.
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., (2006). Public injecting and the need for ‘safer environment interventions’ in the reduction of drug-related harm. Addiction, 101:1385–1393.
   Google Scholar
• Shannon, K., Kerr, T., Allinott, S., Chettiar, J., Shoveller, J., Tyndall, M. W. (2007). Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Social Science and Medicine, 66:911–921.
   PubMedGoogle Scholar
• Small, W., Rhodes, T., Wood, E., Kerr, T. (2007). Public injection settings in Vancouver: physical environment, social context and risk. International Journal of Drug Policy, 18:27–36.
   PubMed Web of Science ®Google Scholar
• Small, W., Kerr, T., Charette, J., Schechter, M. T., Spitall, P. M. (2006). Impacts of an intensified police activity on injection drug users: evidence from an ethnographic investigation. International Journal of Drug Policy, 17:85–95.
   Web of Science ®Google Scholar
• Song, J. Y., Safaeian, M., Strathdee, S. A., Vlahov, D., Celentano, D. D. (2000). The prevalence of homelessness among injection drug users with and without HIV infection. Journal of Urban Health, 77, 678–687.
   PubMed Web of Science ®Google Scholar
• Spittal, P. M., Craib, K. J., Teegee, M., Baylis, C., Christian, W. M., Moniruzzaman, A. K., (2007). The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. International Journal of Circumpolar Health, 66:226–240
   PubMedGoogle Scholar
• Spradling, P. R., Richardson, J. T., Buchacz, K., Moorman, A. C., Finelli, L., Bell, B. P., Brooks,J. T., the HIV Outpatient Study Investigators. (2010). Trends in hepatitis C virus infection among patients in the HIV outpatient study, 1996–2007. Journal of the Acquired Immune Deficiency Syndromes. 53:388–396.
   PubMedGoogle Scholar
• Strathdee, S. A., van Ameijden, E. J., Mesquita, F., Wodak, A., Rana, S., Vlahov, D. (1998). Can HIV epidemics among injection drug users be prevented? AIDS, 12, s71–s79.
   Google Scholar
• Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M., Montaner, J. S. G., (1997a). Needle exchange is not enough: lessons from the Vancouver injecting drug users study. AIDS, 11;F59–F65.
   Google Scholar
• Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G., Rekart, M., (1997b). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92:1339–1347
   PubMed Web of Science ®Google Scholar
• Tyndall, M. W., Currie, P., Spittal, P., Li, K., Wood, E., O’Shaughnessy, M. V., Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17;887–893.
   PubMedGoogle Scholar
• Tyndall, M. W., Craib, K. J. P., Currie, S., Li, K., O’Shaughnessy, M. V., Schechter, M. T. (2001). Impact of HIV infection on mortality in a cohort of injection drug users. Journal of the Acquired Immune Deficiency Syndrome, 28:351–357.
   PubMed Web of Science ®Google Scholar
• Wood, A. R., Wood, E., Lai, C., Tyndall, M. W., Montaner, J. S. G., Kerr, T. (2008). Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. International Journal of Drug Policy. 19:183–188.
   PubMed Web of Science ®Google Scholar
• Wood, E., Montaner, J. S., Li, K., Zhang, R., Barney, L., Strathdee, S. A., (2008). Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. American Journal of Public Health, 98:515–519.
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Kerr, T., Hogg, R. S., (2001). Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? Canadian Medical Association Journal, 165, 405–410.
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T. (2006). What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. International Journal of Drug Policy, 17:55–60.
   Web of Science ®Google Scholar
• Wood, E., Kerr, T., Spittal, P. M., Small, W., Tyndall, M. W., O’Shaughnessy, M. V., (2003). An evaluation of a peer-run ‘unsanctioned’ syringe exchange program. Journal of Urban Health, 80:455–464.
   PubMed Web of Science ®Google Scholar
• Wood, E., Spittal, P. M., Li, K., Ken, T., Miller, C. L., Nogg, R. S., Montaner, J. S., Schechter, M. T. (2004). Inability to access addiction treatment and risk of HIV-infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 36:750–754.
   PubMed Web of Science ®Google Scholar